Early T-cell precursor acute lymphoblastic leukaemia

The Lancet Oncology

Volumn 10, Issue 2, 2009, Pages 105-106

  Taub, Jeffrey W ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CD8 ANTIGEN; CLOFARABINE; GAMMA SECRETASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; NELARABINE; PREDNISONE; T6 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR LMO1; TRANSCRIPTION FACTOR LYL1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; CELL DIFFERENTIATION; CELL LINEAGE; CHILDHOOD LEUKEMIA; GENE DELETION; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKEMIA REMISSION; MONOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN TARGETING; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; THYMOCYTE; TREATMENT RESPONSE;

HUMANS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 58749112011     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70010-5     Document Type: Letter

References (10)

1. Pui C.H., Robison L.L., and Look A.T. Acute lymphoblastic leukaemia. Lancet 371 (2008) 1030-1043
2. Coustan-Smith E., Mullighan C.G., Onciu M., et al. Early T-cell precursor leukaemia: a subtype of high-risk acute lymphoblastic leukaemia. Lancet Oncol 10 (2009) 147-156
3. Bell J.J., and Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452 (2008) 764-767
4. Baldus C.D., Martus P., Burmeister T., et al. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol 25 (2007) 3739-3745
5. Baldus C.D., Burmeister T., Martus P., et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol 24 (2006) 4714-4720
6. Marcucci G., Maharry K., Whitman S.P., et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 25 (2007) 3337-3343
7. Larson R.A. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine. Semin Oncol 34 6 suppl 5 (2007) S13-S20
8. Gidwani P., Ramesh K.H., Liu Y., et al. The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report. Chemotherapy 54 (2008) 120-124
9. Tsapis M., Lieb M., Manzo F., et al. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway. Int J Biochem Cell Biol 39 (2007) 1500-1509
10. Real P.J., Tosello V., Palomero T., et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 15 (2009) 50-58